Professorship for Cellular Immunotherapies in Cancer
Prof. Dr. Judith Feucht has taken up her W2 professorship for Cellular Immunotherapies in Cancer at the Faculty of Medicine on September 1, 2023. Prof. Feucht has dedicated her scientific career to CAR-T cell therapy, which has achieved remarkable clinical success in certain hematological diseases, leading to the approval of CAR therapy by the FDA and EMA. Despite the clinical success, treatment with currently approved CAR designs leads to a complete cure in only a fraction of patients. Her research group therefore aims to improve and expand cellular therapies by reprogramming immune cells through innovative gene editing and cell engineering strategies.
Learn more